ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
7,789.70
0.52%
S&P ASX All Technology
3,450.00
0.25%
Brent Oil
70.285
0.00%
US Dollar vs AUD
1.57978
-0.06%
Bitcoin
84,057.12
0.12%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Palatin Technologies Inc New (PTN)

  7. Palatin Technologies Inc New (PTN) News

PTN

Palatin Technologies (PTN)

Palatin Technologies Inc New
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:PTN
DateTimeSourceHeadlineSymbolCompany
15/02/202508:49Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsAMEX:PTNPalatin Technologies Inc New
14/02/202501:14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:PTNPalatin Technologies Inc New
13/02/202523:30PR Newswire (US)Palatin Reports Second Quarter Fiscal Year 2025 Financial Results and Provides Business UpdateAMEX:PTNPalatin Technologies Inc New
12/02/202522:12Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:PTNPalatin Technologies Inc New
11/02/202509:01Edgar (US Regulatory)Form 8-K - Current reportAMEX:PTNPalatin Technologies Inc New
11/02/202508:00PR Newswire (US)Palatin to Report Second Quarter Fiscal Year 2025 Results; Teleconference and Webcast to be held on February 13, 2025AMEX:PTNPalatin Technologies Inc New
11/02/202504:36Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:PTNPalatin Technologies Inc New
08/02/202500:00PR Newswire (US)Palatin Announces $4.7 Million Registered Direct Offering and Concurrent Private PlacementAMEX:PTNPalatin Technologies Inc New
06/02/202523:30PR Newswire (US)Palatin Completes Phase 2 Obesity Study With MC4R Bremelanotide Plus GLP-1/GIP TirzepatideAMEX:PTNPalatin Technologies Inc New
28/01/202523:30PR Newswire (US)Palatin Provides Update on Anticipated 2025 Corporate MilestonesAMEX:PTNPalatin Technologies Inc New
19/12/202423:30PR Newswire (US)Palatin Announces Positive Phase IIb BREAKOUT Study Results in Patients with Type 2 Diabetic NephropathyAMEX:PTNPalatin Technologies Inc New
17/12/202401:25Edgar (US Regulatory)Form 8-K - Current reportAMEX:PTNPalatin Technologies Inc New
16/12/202423:30PR Newswire (US)Palatin Announces Exercise of Warrants for Approximately $3.4 Million Gross ProceedsAMEX:PTNPalatin Technologies Inc New
25/11/202423:30PR Newswire (US)Palatin Announces Completion of Patient Enrollment in Phase 2 Study of Orally Administered Melanocortin Agonist PL8177 in Ulcerative ColitisAMEX:PTNPalatin Technologies Inc New
15/11/202401:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:PTNPalatin Technologies Inc New
15/11/202401:00Edgar (US Regulatory)Form 8-K - Current reportAMEX:PTNPalatin Technologies Inc New
14/11/202423:30PR Newswire (US)Palatin Reports First Quarter Fiscal Year 2025 Operating/Financial ResultsAMEX:PTNPalatin Technologies Inc New
09/11/202401:57PR Newswire (US)Palatin to Report First Quarter Fiscal Year 2025 Results; Teleconference and Webcast to be held on November 14, 2024AMEX:PTNPalatin Technologies Inc New
04/11/202423:30PR Newswire (US)Palatin Presents Data on Novel Melanocortin 4 Receptor Selective Oral Small Molecule PL7737 Obesity Program at ObesityWeek® 2024AMEX:PTNPalatin Technologies Inc New
31/10/202422:30PR Newswire (US)Palatin Completes Enrollment in Phase 2 Clinical Study of Bremelanotide (MC4R Agonist) Co-Administered with Tirzepatide (GLP-1/GIP) for the Treatment of ObesityAMEX:PTNPalatin Technologies Inc New
31/10/202400:07Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:PTNPalatin Technologies Inc New
30/10/202415:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:PTNPalatin Technologies Inc New
24/10/202422:30PR Newswire (US)Inflammatory Disease Healing Data via Palatin's Novel Melanocortin Receptor Agonists Presented at the 19th Annual Peptide Therapeutics SymposiumAMEX:PTNPalatin Technologies Inc New
23/10/202422:30PR Newswire (US)Palatin Presents Foundational Data on Novel and Highly Selective Melanocortin 4 Receptor Agonists at the 19th Annual Peptide Therapeutics SymposiumAMEX:PTNPalatin Technologies Inc New
23/10/202407:31Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]AMEX:PTNPalatin Technologies Inc New
08/10/202407:15PR Newswire (US)Palatin Receives Notice of Non-Compliance from NYSE AmericanAMEX:PTNPalatin Technologies Inc New
01/10/202422:15Edgar (US Regulatory)Form 8-K - Current reportAMEX:PTNPalatin Technologies Inc New
01/10/202421:30PR Newswire (US)Palatin Reports Fourth Quarter and Fiscal Year Ended 2024 Financial Results, Provides Update on Clinical Programs, Strategic Priorities, and Anticipated MilestonesAMEX:PTNPalatin Technologies Inc New
01/10/202406:31Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]AMEX:PTNPalatin Technologies Inc New
26/09/202421:30PR Newswire (US)Palatin to Report Fourth Quarter and Fiscal Year End 2024 ResultsAMEX:PTNPalatin Technologies Inc New
 Showing the most relevant articles for your search:AMEX:PTN

Your Recent History

LSE
AR06
Rbts Plc 28
NASDAQ
SMH
VanEck Semiconductor ETF
BIT
1HOOD
Robinhood Markets
LSE
FT54
Akademiska 41
NASDAQ
CMCT
Creative Media and Commu...
LSE
93JJ
Japan Fin. 24 A
TG
ETA
Paradox Interactive AB
LSE
KN40
Morg.st.b.v 25
LSE
45CW
Ab Sveriges 30
LSE
NMCN
Nmcn
LSE
XUEK
X Europe Ex Uk
BIT
P1QNT0
BNP Paribas Issuance
BIT
UV8C6V
UniCredit Bank
NASDAQ
WCLD
WisdomTree Cloud Computing
LSE
80GT
Jp Morgan.31
LSE
96IK
Int.fin. 27
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads